肾炎康复片联合激素治疗儿童紫癜性肾炎的临床疗效及安全性分析

doi:10.3969/j.issn.1674-490X.2019.02.006

医学研究与教育 ›› 2019, Vol. 36 ›› Issue (2): 28-32.DOI: 10.3969/j.issn.1674-490X.2019.02.006

肾炎康复片联合激素治疗儿童紫癜性肾炎的临床疗效及安全性分析

霍丽娇¹,王琨²,柏金秀³,马腾腾¹,魏继红³

1.河北大学医学院, 河北保定 071000;
2.陆军第八十二集团军医院儿科, 河北保定071000;
3.河北大学附属医院儿科, 河北保定 071000

收稿日期:2019-01-04 出版日期:2019-04-25 发布日期:2019-04-25
通讯作者: 柏金秀(1971—),女,河北保定人,主任医师,硕士,主要从事儿科呼吸及肾病方面的研究。E-mail: baijinx@163.com
作者简介:霍丽娇(1992—),女,河北邢台人,医师,在读硕士,主要从事儿科肾病方面的研究。

Received:2019-01-04 Online:2019-04-25 Published:2019-04-25

摘要/Abstract

摘要： 目的分析肾炎康复片联合糖皮质激素治疗儿童紫癜性肾炎的临床疗效及安全性。方法 2018年1月至11月河北大学附属医院收治的80例紫癜性肾炎患儿为实验对象,依据入院先后顺序分为对照组(n=39)、观察组(n=41),2组患儿均开展抗过敏等相关对症治疗,对照组给予糖皮质激素治疗,观察组在对照组的基础上给予肾炎康复片治疗,对比2组患儿的临床效果、临床症状消退时间、24 h尿蛋白定量、血清IgA水平及不良反应。结果对照组和观察组比较临床疗效差异有统计学意义(Z=1.688,P=0.046);与对照组比较,观察组患儿的临床症状消退时间较短(P<0.05);治疗前,与对照组比较,观察组患儿的24 h尿蛋白定量及血清IgA水平差异无统计学意义(P>0.05);治疗后,与对照组比较,观察组患儿的24 h尿蛋白定量及血清IgA水平改善明显;与对照组不良反应发生率(20.51%)比较,实验组(2.45%)较低(P<0.05)。结论针对紫癜性肾炎患儿在糖皮质激素治疗的基础上给予肾炎康复片治疗,在提升治疗效果的同时减少不良反应,改善24 h尿蛋白定量、血清IgA水平,缩短临床症状消退时间。

关键词: 肾炎康复片, 糖皮质激素, 儿童紫癜性肾炎, 临床疗效, 安全性

Abstract: Objective To analyze the clinical efficacy and safety of Shenyankangfupian combined with glucocorticoid in the treatment of children with Henoch-Schönlein purpura nephritis. Methods 80 children with Henoch-Schönlein purpura nephritis admitted to Affiliated Hospital of Hebei University from January 2018 to November 2018 were divided into control group(n=39)and observation group(n=41)according to the order of admission.The patients of the two groups were given symptomatic treatment such as anti-allergy, the patients in the control group were given glucocorticoid therapy, and the patients in the observation group were given Shenyankangfupian on the basis of the control group, and the treating. results of the two groups were compared. The clinical effect, clinical symptoms subsidence time, urinary protein excretion in 24-hour collections, serum IgA and adverse reactions of the patients were examined. Results There was statistically significant difference between the control group and the observation group in the clinical effect(Z=1.688, P=0.046). Compared with the control group, the clinical symptom regression time of the observation group was shortened(P<0.05). Before treatment, compared with the control group, there was no statistically significant difference in the urinary protein excretion in 24-hour collections and serum IgA level of the observation group(P>0.05). After treatment, compared with the control group, the urinary protein excretion in 24-hour collections and serum IgA level of the observation group were significantly improved. Compared with the control group(20.51%), the incidence of adverse reactions in the experimental group(2.45%)was reduced(P<0.05). Conclusion Shenyankangfupian given to children with Henoch-Schönlein purpura nephritis on the basis of glucocorticoid therapy can improve the therapeutic effect and reduce adverse reactions, improve urinary protein excretion in 24-hour collections and serum IgA shorten the time of clinical symptoms subsidence.

Key words: Shenyankangfupian, glucocorticoid, children Henoch-Schö, nlein purpura nephritis, clinical efficacy, safety

中图分类号:

霍丽娇,王琨,柏金秀,马腾腾,魏继红. 肾炎康复片联合激素治疗儿童紫癜性肾炎的临床疗效及安全性分析[J]. 医学研究与教育, 2019, 36(2): 28-32.

参考文献

[1] MAO Y, YIN L, HUANG H, et al. Henoch-Schönlein purpura in 535 Chinese children: clinical features and risk factors for renal involvement[J].Journal of International Medical Research, 2014, 42(4): 1043-1049. DOI: 10.1177/0300060514530879.
[2] SCOTT C, MCCULLOCH M, NOURSE P. Takayasus arteritis in children: a developing world perspective[J]. Annals of Paediatric Rheumatology, 2013, 2(2): 1. DOI: 10.5455/apr.120320130832.
[3] CHEN A C, LIN C L, SHEN T C, et al. Association between allergic diseases and risks of Henoch-Schönlein purpura(HSP)and HSP nephritis: a population-based study[J]. Pediatric Research, 2016,79(4): 559-564. DOI: 10.1038/pr.2015.271.
[4] 李志娟, 李俊, 黄惠梅,等. 霉酚酸酯联合糖皮质激素治疗小儿紫癜性肾炎的疗效观察[J]. 现代生物医学进展, 2017, 17(26): 5177-5180. DOI: 10.13241/j.cnki.pmb.2017.26.041.
[5] 刘永平. 雷公藤联合肾炎康治疗紫癜性肾炎30例疗效观察[J]. 中国伤残医学, 2015,23(3): 171-172. DOI: 10.13214/j.cnki.cjotadm.2015.03.137.
[6] 朱春华, 黄松明. 紫癜性肾炎诊治循证指南(2016)解读[J]. 中华儿科杂志, 2017, 55(9): 654-657. DOI: 10.3760/cma.j.issn.0578-1310.2017.09.003.
[7] CHEN J Y, MAO J H. Henoch-Sch(ö)nlein purpura nephritis in children: incidence, pathogenesis and management[J]. World Journal of Pediatrics, 2015, 11(1): 29-34. DOI: 10.1007/s12519-014-0534-5.
[8] MAO Y, YIN L, XIA H, et al. Incidence and clinical features of paediatric vasculitis in Eastern China: 14-year retrospective study, 1999-2013[J]. Journal of International Medical Research, 2016, 44(3): 710-717. DOI: 10.1177/0300060515621446.
[9] 阿迪力江·喀日, 扎依旦·艾力, 罗燕飞,等. 环磷酰胺联合强的松治疗儿童肾病综合征型紫癜性肾炎的疗效观察[J]. 新疆医科大学学报, 2016, 39(11): 1416-1419. DOI: 10.3969/j.issn.1009-5551.2016.11.017.
[10] 姜敏, 万廷信, 李建华. 肾炎康治疗IgA肾病76例的临床疗效[J]. 中药药理与临床, 2015, 31(2): 185-186. DOI: 10.13412/j.cnki.zyyl.2015.02.102.
[11] 靳晓明, 杨尧, 孙世辉, 等. 基于数据挖掘中医治疗儿童过敏性紫癜辨证和用药规律[J]. 医学研究与教育, 2018, 35(3): 39-43. DOI: 10.3969/j.issn.1674-490X.2018.03.007.
[12] 周波. 肾炎康联合依那普利治疗老年糖尿病肾病疗效评估报道[J]. 医学信息, 2015, 36(41): 235-236. DOI: 10.3969/j.issn.1006-1959.2015.41.339.
[13] 张桂月,王凤君,关美玉.肾炎康联合依那普利对老年糖尿病肾病的治疗价值探讨[J].中国实用医药, 2016,11(11): 130-131. DOI: 10.14163/j.cnki.11-5547/r.2016.11.095.
[14] 朱辟疆, 解冰, 江丽萍. 肾炎康对大鼠系膜增生性肾炎MCP-1的影响[J]. 浙江中西医结合杂志, 2007, 17(11): 665-667. DOI: 10.3969/j.issn.1005-4561.2007.11.003.
[15] 叶婷婷, 王黎萍, 沈建明, 等. 肾炎康复片对肾间质纤维化大鼠基质金属蛋白酶-9/金属蛋白酶组织抑制物-1表达的影响[J]. 山西医药杂志, 2012, 41(18): 900-901. DOI: 10.3969/j.issn.0253-9926.2012.18.007.
[16] 丁云峰, 李志辉, 段翠蓉,等. 肾炎康治疗小儿紫癜性肾炎血尿和蛋白尿的疗效观察[J]. 中国中西医结合儿科学, 2017(5): 39-41. DOI: 10.3969/j.issn.1674-3865.2017.05.013.

肾炎康复片联合激素治疗儿童紫癜性肾炎的临床疗效及安全性分析

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	宫哲轩,武广义. 糖皮质激素治疗不同原因急性肺损伤研究进展[J]. 医学研究与教育, 2023, 40(3): 28-37.
[2]	赵元奎. 丙泊酚联合依托咪酯在老年无痛胃肠镜检查中的效果观察和安全性分析[J]. 医学研究与教育, 2021, 38(1): 17-22.
[3]	黄雅琴,夏月平,牛培. 通心络胶囊治疗冠心病心绞痛症状的研究进展[J]. 医学研究与教育, 2016, 33(3): 52-56.
[4]	解素勇，聂津，张建红，王奕芳，邵伟. 利多卡因联合舒芬太尼硬膜外麻醉在急诊剖宫产术中的应用[J]. 医学研究与教育, 2015, 32(6): 37-40.
[5]	姜旭，王元松，张立英，杨景超，邢丽君，张爱玲，孙文亮. 复荣通脉胶囊治疗糖尿病周围神经病变的临床疗效[J]. 医学研究与教育, 2015, 32(4): 5-9.
[6]	孙菊平，代瑞廷，徐金娥，安迪. 丁苯酞联合尼莫地平对血管性痴呆的疗效观察[J]. 医学研究与教育, 2015, 32(1): 36-39.
[7]	张晓梅,姚亮,高雅丽,刘式浩,董宏伟,牛培. 光疗的基础与临床应用[J]. 医学研究与教育, 2013, 30(3): 1-7.
[8]	孙春伟. 阿德福韦酯联合干扰素α治疗慢性乙型病毒性肝炎[J]. 医学研究与教育, 2011, 28(4): 21-23,37.
[9]	李亚静,田自力,田媛,陆玉香,徐诗聪,鲁素彩,程勇,陈雷,言红健. 内镜下氩等离子凝固术治疗不同类型消化道息肉的疗效分析[J]. 医学研究与教育, 2010, 27(3): 37-39.
[10]	张连祥,李春昕. 通心络胶囊治疗冠心病心绞痛90例临床观察[J]. 医学研究与教育, 2009, 26(2): 62-63.